Ardena’s GCP-compliant bioanalytical services can support regulatory clinical studies through phase I-IV. We analyse matrices such as blood, plasma, urine, CSF, nasal washes, sputum and many others. We are experts in the isolation of PBMCs.
In method development and validation, we use state-of-the-art instrumentation to create the most robust, sensitive assays possible. Samples are analysed within agreed timeframes and in accordance with GCP regulations. The samples will be stored in our secure temperature monitored storage facility (-20°C or -80°C) until analysis.
With our fast turnaround service, we deliver results within required timelines to allow rapid decision making during dose escalation studies. All the results we produce go through rigorous Quality Control (QC) and source verification, which is conducted by our Quality Assurance (QA) team.
The bioanalytical study report can be presented in in-house templates or in a template provided by the customer.